Literature DB >> 10683328

Loss of ATM function enhances recombinant adeno-associated virus transduction and integration through pathways similar to UV irradiation.

S Sanlioglu1, P Benson, J F Engelhardt.   

Abstract

Ataxia telangiectasia is caused by a genetic defect in the ATM gene that results in altered cellular sensitivity to DNA-damaging agents such as gamma-irradiation. ATM deficiency is associated with an increased incidence of neurological disorders, immune deficiency, and cancer. In this report we demonstrate that recombinant adeno-associated virus (rAAV) gene transfer in ATM-deficient fibroblasts is significantly enhanced over normal fibroblast cell lines. This enhancement of rAAV transduction in AT cells is correlated with an increased abundance of circular form rAAV genomes, as well as a higher number of integrated head-to-tail concatamer proviral genomes. Studies evaluating AAV trafficking using Cy3-labeled virus suggest that a nuclear mechanism is responsible for increased rAAV transduction in AT cells, because binding, endocytosis, and nuclear trafficking of virus are unaffected by the AT phenotype. Additionally, the profile of rAAV transduction after UV irradiation is significantly blunted in AT cells, suggesting that the level of DNA repair enzymes normally associated with UV augmentation of viral transduction may already be maximally elevated. These results further expand our understanding of genes involved in rAAV transduction. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683328     DOI: 10.1006/viro.1999.0137

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  25 in total

1.  Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome.

Authors:  L Zentilin; A Marcello; M Giacca
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Effect of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle.

Authors:  S Song; P J Laipis; K I Berns; T R Flotte
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Differential effects of DNA double-strand break repair pathways on single-strand and self-complementary adeno-associated virus vector genomes.

Authors:  Marcela P Cataldi; Douglas M McCarty
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

Review 4.  Viral manipulation of DNA repair and cell cycle checkpoints.

Authors:  Mira S Chaurushiya; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2009-05-26

5.  Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes.

Authors:  Ziying Yan; Roman Zak; Yulong Zhang; John F Engelhardt
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  Host cell DNA repair pathways in adeno-associated viral genome processing.

Authors:  Vivian W Choi; Douglas M McCarty; R Jude Samulski
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

7.  Adeno-Associated Virus Genome Interactions Important for Vector Production and Transduction.

Authors:  Anna C Maurer; Matthew D Weitzman
Journal:  Hum Gene Ther       Date:  2020-05       Impact factor: 5.695

8.  Adeno-associated virus and adenovirus coinfection induces a cellular DNA damage and repair response via redundant phosphatidylinositol 3-like kinase pathways.

Authors:  Roy F Collaco; Joyce M Bevington; Vipul Bhrigu; Vivian Kalman-Maltese; James P Trempe
Journal:  Virology       Date:  2009-07-23       Impact factor: 3.616

9.  The Mre11/Rad50/Nbs1 complex limits adeno-associated virus transduction and replication.

Authors:  Rachel A Schwartz; Jose Alejandro Palacios; Geoffrey D Cassell; Sarah Adam; Mauro Giacca; Matthew D Weitzman
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

10.  Adeno-associated virus site-specific integration is mediated by proteins of the nonhomologous end-joining pathway.

Authors:  Shyam Daya; Nenita Cortez; Kenneth I Berns
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.